Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2020

Litigation and non-routine costs, net of insurance recoveries

Litigation and non-routine costs, net include the following costs and recoveries (in thousands):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019


Litigation and non-routine costs, net:
Audit Committee Investigation and related matters (1) (2)	$	105	$	32,051	$	(6,106)	$	69,509
Legal fees and expenses	—		—		—		2
Litigation settlements	—		799,973		—		812,208


Total costs	105		832,024		(6,106)		881,719
Insurance recoveries	—		—		(2,471)		(48,420)
Other recoveries (3)	—		—		—		(26,536)
Total	$	105	$	832,024	$	(8,577)	$	806,763

___________________________________

(1)Includes all fees and costs associated with various litigations and investigations prompted by the results of the 2014 investigation conducted by the audit committee (the “Audit Committee”) of the Company’s Board of Directors (the “Audit Committee Investigation”), including fees and costs incurred pursuant to the Company’s advancement obligations, litigation related thereto and in connection with related insurance recovery matters, net of accrual reversals.

(2)The negative balance for the nine months ended September 30, 2020 is a result of estimated costs accrued in prior periods that exceeded actual expenses incurred.

(3)Represents the surrender of 2.9 million Limited Partner OP Units in connection with an SEC settlement entered into by principals of the Company’s former external manager.

Summary of equity-based compensation expense

The following is a summary of equity-based compensation expense for the three and nine months ended September 30, 2020 and 2019 (in thousands):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019


Restricted Shares	$	—	$	—	$	—	$	77
Time-Based Restricted Stock Units (1)	1,412		1,272		4,195		3,748
Long-Term Incentive-Based Restricted Stock Units	1,416		1,455		3,916		4,074
Deferred Stock Units	53		82		1,071		1,101
Stock Options	330		335		955		899
Total	$	3,211	$	3,144	$	10,137	$	9,899

___________________________________

(1)Includes stock compensation expense attributable to awards for which the requisite service period begins prior to the assumed future grant date.